CIK 0001439725 · Non-accelerated filer<br>Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203986492
- Phone
- 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Open-market sale Chief Accounting Officer sold 224 shares at an average $0.36 ($80)
- 4 Open-market sale Chief Development Officer sold 445 shares at an average $0.36 ($158)
- 4 Open-market sale Chief Commercial Officer sold 477 shares at an average $0.36 ($170)
- 4 Open-market sale President & CEO sold 3,775 shares at an average $0.36 ($1,344)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 992 shares at an average $0.36 ($353)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Executive or director change
- 4 Option exercise Director acquired 26,368 shares (option exercise)
- 4 Option exercise Director acquired 46,686 shares (option exercise)
- 4 Option exercise Director acquired 46,686 shares (option exercise)
- 8-K Event Delisting notice
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 31 · 602 filings